Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleus Accumbens | 7 | 2017 | 42 | 2.150 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 8 | 2014 | 30 | 1.600 |
Why?
|
| Neurons | 11 | 2014 | 864 | 1.410 |
Why?
|
| Ethanol | 7 | 2014 | 307 | 1.240 |
Why?
|
| Dopamine | 3 | 2024 | 102 | 0.860 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 2 | 2014 | 6 | 0.790 |
Why?
|
| Action Potentials | 4 | 2017 | 103 | 0.750 |
Why?
|
| Corpus Striatum | 3 | 2023 | 96 | 0.650 |
Why?
|
| Synaptic Transmission | 3 | 2024 | 151 | 0.630 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 141 | 0.580 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 14 | 0.560 |
Why?
|
| Binge Drinking | 1 | 2017 | 29 | 0.540 |
Why?
|
| Long-Term Synaptic Depression | 2 | 2014 | 15 | 0.530 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2012 | 75 | 0.520 |
Why?
|
| Long-Term Potentiation | 2 | 2014 | 43 | 0.520 |
Why?
|
| Drug Tolerance | 3 | 2009 | 28 | 0.470 |
Why?
|
| Neural Inhibition | 1 | 2014 | 26 | 0.470 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 417 | 0.380 |
Why?
|
| Patch-Clamp Techniques | 7 | 2014 | 126 | 0.340 |
Why?
|
| Interpeduncular Nucleus | 2 | 2024 | 21 | 0.340 |
Why?
|
| Locomotion | 2 | 2019 | 111 | 0.330 |
Why?
|
| Animals | 20 | 2024 | 19771 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 3222 | 0.300 |
Why?
|
| Interleukin-4 | 1 | 2008 | 141 | 0.290 |
Why?
|
| Potassium Channels, Calcium-Activated | 2 | 2004 | 14 | 0.290 |
Why?
|
| Muscle, Smooth | 1 | 2008 | 138 | 0.280 |
Why?
|
| Mice | 12 | 2024 | 10340 | 0.280 |
Why?
|
| Feeding Behavior | 1 | 2008 | 314 | 0.260 |
Why?
|
| Electrophysiology | 3 | 2014 | 89 | 0.240 |
Why?
|
| Autistic Disorder | 1 | 2007 | 169 | 0.230 |
Why?
|
| Intellectual Disability | 1 | 2007 | 168 | 0.230 |
Why?
|
| Morphine | 1 | 2004 | 52 | 0.230 |
Why?
|
| Dopamine Agonists | 2 | 2014 | 19 | 0.220 |
Why?
|
| Receptors, Glycine | 1 | 2002 | 8 | 0.210 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2023 | 32 | 0.200 |
Why?
|
| Calcium | 4 | 2012 | 560 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2014 | 861 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2008 | 570 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2009 | 2002 | 0.170 |
Why?
|
| Dopaminergic Neurons | 1 | 2019 | 32 | 0.160 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 37 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2019 | 2102 | 0.150 |
Why?
|
| Potassium Channel Blockers | 2 | 2017 | 25 | 0.150 |
Why?
|
| Cocaine | 1 | 2019 | 87 | 0.150 |
Why?
|
| Rats | 5 | 2008 | 1915 | 0.150 |
Why?
|
| Hippocampus | 2 | 2017 | 243 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2019 | 199 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2017 | 26 | 0.140 |
Why?
|
| Membrane Potentials | 3 | 2010 | 137 | 0.140 |
Why?
|
| Luciferases | 1 | 2017 | 109 | 0.140 |
Why?
|
| Ion Channels | 1 | 2017 | 88 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2014 | 30 | 0.140 |
Why?
|
| Neural Pathways | 1 | 2017 | 97 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2019 | 379 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2019 | 586 | 0.130 |
Why?
|
| Male | 8 | 2019 | 27969 | 0.130 |
Why?
|
| N-Methylaspartate | 2 | 2007 | 14 | 0.120 |
Why?
|
| Synapses | 1 | 2017 | 179 | 0.120 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2012 | 44 | 0.120 |
Why?
|
| Habenula | 1 | 2015 | 15 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 34 | 0.120 |
Why?
|
| Ventral Tegmental Area | 1 | 2015 | 32 | 0.120 |
Why?
|
| Spider Venoms | 1 | 2014 | 2 | 0.120 |
Why?
|
| Quinpirole | 1 | 2014 | 5 | 0.120 |
Why?
|
| Benzopyrans | 1 | 2014 | 7 | 0.120 |
Why?
|
| Adamantane | 1 | 2014 | 4 | 0.120 |
Why?
|
| Charybdotoxin | 1 | 2014 | 5 | 0.120 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2014 | 22 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 22 | 0.120 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 31 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 46 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 89 | 0.110 |
Why?
|
| Potassium | 1 | 2014 | 110 | 0.110 |
Why?
|
| RNA Interference | 1 | 2017 | 592 | 0.110 |
Why?
|
| Cell Line | 3 | 2008 | 2019 | 0.110 |
Why?
|
| Nicotine | 1 | 2015 | 111 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 855 | 0.110 |
Why?
|
| Glycine | 2 | 2004 | 46 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2009 | 620 | 0.100 |
Why?
|
| Anxiety | 1 | 2015 | 400 | 0.100 |
Why?
|
| Ion Channel Gating | 2 | 2017 | 44 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2017 | 2893 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2012 | 155 | 0.090 |
Why?
|
| Humans | 10 | 2019 | 60133 | 0.090 |
Why?
|
| Protein Methyltransferases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 2 | 2007 | 4 | 0.090 |
Why?
|
| Membrane Lipids | 1 | 2009 | 27 | 0.080 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2009 | 2 | 0.080 |
Why?
|
| Affect | 1 | 2010 | 125 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2009 | 81 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 195 | 0.080 |
Why?
|
| Time Factors | 2 | 2014 | 3621 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1227 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2010 | 218 | 0.080 |
Why?
|
| Histamine | 1 | 2008 | 27 | 0.080 |
Why?
|
| Alcoholism | 2 | 2009 | 308 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2008 | 35 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2017 | 230 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 79 | 0.070 |
Why?
|
| RNA Stability | 1 | 2008 | 94 | 0.070 |
Why?
|
| Toxins, Biological | 1 | 2007 | 6 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 118 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2007 | 64 | 0.070 |
Why?
|
| RNA Splicing | 1 | 2008 | 160 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 305 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2004 | 165 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 196 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 257 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 381 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 354 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 525 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2009 | 1139 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 643 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 419 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 34 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 31 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2004 | 52 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 39 | 0.060 |
Why?
|
| Tegmentum Mesencephali | 1 | 2024 | 6 | 0.060 |
Why?
|
| Dendrites | 1 | 2004 | 56 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 70 | 0.060 |
Why?
|
| GABAergic Neurons | 1 | 2024 | 33 | 0.060 |
Why?
|
| Peptides | 1 | 2007 | 550 | 0.050 |
Why?
|
| Clozapine | 1 | 2003 | 30 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1543 | 0.050 |
Why?
|
| Receptors, Presynaptic | 1 | 2023 | 1 | 0.050 |
Why?
|
| Strychnine | 1 | 2002 | 4 | 0.050 |
Why?
|
| Glycine Agents | 1 | 2002 | 5 | 0.050 |
Why?
|
| Picrotoxin | 1 | 2002 | 5 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2002 | 6 | 0.050 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2002 | 19 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 737 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2009 | 690 | 0.050 |
Why?
|
| Oocytes | 1 | 2003 | 192 | 0.050 |
Why?
|
| Zinc | 1 | 2002 | 91 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2003 | 313 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2081 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2004 | 505 | 0.040 |
Why?
|
| Mutation | 1 | 2007 | 2474 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1472 | 0.040 |
Why?
|
| Cadmium Chloride | 1 | 2017 | 2 | 0.040 |
Why?
|
| 4-Aminopyridine | 1 | 2017 | 3 | 0.040 |
Why?
|
| Tetrodotoxin | 1 | 2017 | 8 | 0.040 |
Why?
|
| Tetraethylammonium | 1 | 2017 | 8 | 0.040 |
Why?
|
| Sodium Channel Blockers | 1 | 2017 | 10 | 0.040 |
Why?
|
| Synaptic Potentials | 1 | 2017 | 7 | 0.040 |
Why?
|
| Camptothecin | 1 | 2017 | 23 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 346 | 0.030 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 24 | 0.030 |
Why?
|
| Nerve Net | 1 | 2015 | 93 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 119 | 0.030 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 1 | 0.020 |
Why?
|
| Immobility Response, Tonic | 1 | 2010 | 1 | 0.020 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2010 | 4 | 0.020 |
Why?
|
| Electroshock | 1 | 2010 | 3 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 22 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 32 | 0.020 |
Why?
|
| Maze Learning | 1 | 2010 | 52 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2010 | 33 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2010 | 25 | 0.020 |
Why?
|
| Sucrose | 1 | 2010 | 30 | 0.020 |
Why?
|
| Food Preferences | 1 | 2010 | 55 | 0.020 |
Why?
|
| Fear | 1 | 2010 | 67 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 147 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 354 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 676 | 0.020 |
Why?
|
| COS Cells | 1 | 2007 | 175 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 343 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2007 | 113 | 0.020 |
Why?
|
| Cerebellum | 1 | 2007 | 94 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1526 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 603 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2004 | 133 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2004 | 88 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2003 | 11 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2003 | 67 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 472 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 855 | 0.010 |
Why?
|
| Female | 1 | 2003 | 31235 | 0.000 |
Why?
|